Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]

Final scope (PDF 147 KB)

Final stakeholder list (PDF 144 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 324 KB)

Draft scope post referral (PDF 156 KB)

Supporting documentation (MSWord 47 KB)

Note

Note

Note

Draft scope post referral (PDF 207 KB)